Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population

NCT00600236 is registered in ClinicalTrials.gov with Asociación para Evitar la Ceguera en México as lead sponsor.

NCT NCT00600236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00600236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population
Lead sponsor
Asociación para Evitar la Ceguera en México
Phase
Phase 3
Overall status
Withdrawn
Start date
September 30, 2004
Completion date
January 31, 2008
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2, proliferative diabetic retinopathy